Pharma Journalist -

SMi Group are delighted to announce the 6th annual Pharmaceutical Freeze Drying Technology conference, being held this June 2018! Read on for a massive £400 off. Optimizing…
Read More...

Puma Biotechnology and Pint Pharma International have entered into an agreement for Pint Pharma to commercialize NERLYNX (neratinib) in Argentina, Brazil, Chile, Colombia, Mexico and…
Read More...

MRI analysis of patients who received intradiscal injections of human dermal fibroblasts (HDFs) shows significant improvement in disc height after six months. This is the latest…
Read More...

PharmaCyte Biotech, Inc. announced that vials of cells from PharmaCyte’s Master Cell Bank (MCB) have been shipped by Eurofins Lancaster Laboratories (Eurofins) to Austrianova’s…
Read More...

Dr. Reddy’s Laboratories Ltd and its subsidiary, Promius Pharma, LLC announced the filing of New Drug Application (NDA) for its migraine candidate DFN-02 with the U.S. Food and Drug…
Read More...

Synlogic announced that the first patient was dosed in its Phase 1b/2a clinical trial of SYNB1020. SYNB1020 is a Synthetic Biotic medicine being developed for the treatment of…
Read More...

Ahead of 18th annual Pain Therapeutics Conference (London, 21 - 22 May) SMi Group recently have caught up with Neil Singla, Founder & Chief Scientific Officer at Lotus Clinical…
Read More...

PharmAbcine announced that U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading clinical compound TTAC-0001 for “treatment of Glioblastoma…
Read More...

Martin Pharmaceuticals, a clinical stage pharmaceutical company focused on repurposing already-approved drugs to offer life-changing advances to patients afflicted with rare (orphan)…
Read More...

Aditlys is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment for chronic kidney disease. Aditlys’…
Read More...